Axcella Health Announces Reverse Stock Split


Axcella Health, a leading biotechnology company, has announced its plans to effect a 1-for-25 reverse stock split. The news has resulted in a dip in the company’s stock price during after-hours trading.

Date and Trading Basis

The reverse split is scheduled to take place on September 18th, with the company’s shares set to begin trading on a reverse stock split basis starting September 19th.

Stock Performance

At 5:44 p.m. EDT, Axcella’s stock was trading 18.7% lower, at 82 cents per share. Trading volume exceeded 2.3 million shares. The stock had already registered a 15.1% loss during the regular session, closing at $1.01 per share.

However, despite the recent decline, the stock has witnessed an impressive year-to-date gain of over 208%.

Objective and Rationale

The primary objective behind the reverse stock split is to increase the per-share market price and meet the Nasdaq’s minimum per-share bid price requirement. By achieving this, Axcella aims to enhance its market standing.

Innovative Approach

Axcella Health is dedicated to pioneering a new approach in addressing the complexities of diseases by utilizing compositions of endogenous metabolic modulators.

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Frequency Electronics Sees Stock Rise After Positive Q1 Financial Results

Next Post

ECR Minerals Announces Leadership Changes

Related Posts